Biedermann Motech Launches MDS Injection Screw for its Polyaxial Humerus Plating Systems

Biedermann Motech, a developer of polyaxial screw technologies, has launched the first injection screw that can be used through, and in combination with, its polyaxial locking plate systems.
 
The MDS Injection Screw can be utilized to deliver injectable bone void fillers to a surgical site and is compatible with MDS humerus plating systems. It was developed as an option for the systems to offer stable fixation in osteoporotic and complex fractures.
 
The current MDS plating systems utilize Next Generation Polyaxial Locking Technology, which includes 40-degree polyaxial locking for optimal plate and screw placement, a strong and consistent locking mechanism at every screw angle and a low profile construct. By adding the MDS Injection Screw to the system, surgeons will have additional options in the treatment of complex humeral fractures. Biedermann Motech is the first company to offer such a technology for extremity surgery.

“Biedermann Motech first introduced the combination of fenestrated augmentable polyaxial screws for complex spine reconstructions more than 15 years ago,” said Markku Biedermann, chairman of Biedermann Motech Inc., “and we are very excited to now introduce this sophisticated technology for the fixation of bone fractures and bone reconstructions of the humerus.”
 
Biedermann Motech is a mid-sized, family owned group of companies with headquarters in Germany (Villingen-Schwenningen) and the United States (Miami, Fla.). Since 1916 the company has been working in synergy with surgeons to solve significant clinical challenges through the development of next-generation technology. Its core competency is the development, production, and distribution of innovative implants and instruments for spinal and extremity surgery. Biedermann Motech researches, develops, manufactures, and distributes implant systems in collaboration with healthcare professionals, technology partners, scientific institutions and specialized companies with the goal of achieving improved clinical outcomes.